Article
A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity.
Journal of immunological methods - 1 Jan 2021
Herzig Maryanne C, Delavan Christopher P, Jensen Katherine J, Cantu Carolina, Montgomery Robbie K, Christy Barbara A, Cap Andrew P, Bynum James A
Abstract excerpt
BACKGROUND: Mesenchymal stromal cells (MSCs) have been proposed for treatment of acute respiratory distress syndrome (ARDS), graft versus host disease (GVHD), wound healing and trauma. A consensus is building that immunomodulation by MSCs is important for therapeutic potential. MSCs suppress peripheral blood mononuclear cell (PBMC) proliferation in vitro, potentially reflecting an ability to suppress PBMC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
